Previous Article | Next Article 
Journal of Clinical Microbiology, June 2001, p. 2294-2297, Vol. 39, No. 6
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.6.2294-2297.2001
Biofilm Formation by Gram-Negative Bacteria on Central Venous
Catheter Connectors: Effect of Conditioning Films in a
Laboratory Model
R.
Murga,*
J. M.
Miller, and
R. M.
Donlan
Biofilm Research Laboratory, Division of
Healthcare Quality Promotion, National Center for Infectious
Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia
Received 29 November 2000/Returned for modification 7 March
2001/Accepted 29 March 2001
 |
ABSTRACT |
Human blood components have been shown to enhance biofilm formation
by gram-positive bacteria. We investigated the effect of human blood on
biofilm formation on the inner lumen of needleless central venous
catheter connectors by several gram-negative bacteria, specifically
Enterobacter cloacae, Pseudomonas aeruginosa, and Pantoea agglomerans. Results suggest that a conditioning
film of blood components promotes biofilm formation by these organisms in an in vitro system.
 |
TEXT |
Evidence that biofilms can develop
on intravascular devices, including central venous catheters (CVCs),
has been well documented (7, 16). Colonization of the
outer lumen of the catheter by microorganisms is usually the result of
the catheter's proximity to skin flora. Colonization of the inner
lumen of catheters (specifically by gram-negative rods) may be the
result of a break in aseptic handling of the device prior to insertion
or of the exposure of the end connectors to water, soil, or
contaminated intravenous (i.v.) fluids. Both gram-positive and
gram-negative bacteria have been isolated from biofilms on CVCs
(6, 14, 15).
The initial event in the formation of a biofilm is the adhesion of the
organisms to the surface. Material surfaces adsorb proteins or other
organic materials when exposed in a fluid environment. These organic
coatings, or conditioning films, have been shown to alter the material
surface properties and affect microbial attachment (3,
18). It is standard practice for blood to be drawn through a CVC
to ensure proper catheter placement (M. Bell, personal communication);
although the catheter is flushed promptly afterwards, it would not be
unreasonable to expect some adsorption of blood proteins to condition
the exposed surfaces. The blood proteins fibrinogen and fibronectin
affect the adhesion of gram-positive bacteria to biomaterials. For
example, both of these purified plasma proteins enhanced the binding of
Staphylococcus aureus to surfaces while inhibiting the
binding of Staphylococcus epidermidis (9, 12)
and gram-negative bacteria (1, 13, 19-21). Gram-negative
bacteria, however, do colonize CVCs and other vascular access devices
exposed to human blood components, resulting in bloodstream infections
(23.2% of the central line-associated infections in intensive care
units for 1986 to 1989 and 19.5% for 1990 to 1995) (10).
This finding suggests that these organisms must not be completely
inhibited by surfaces conditioned with whole blood.
The objective of this study was to evaluate the effect of human blood
on the adhesion and biofilm formation of gram-negative organisms on the
inner surface of CVC needleless connectors (NCs) in a laboratory model
using a commercially available i.v. fluid as a nutrient.
In an earlier study, we reported the occurrence of biofilms on CVC NCs
(6) and showed that biofilms on these devices were comprised of both gram-positive and gram-negative bacteria. Our purpose
in the present study was to further investigate biofilm formation on
NCs under controlled laboratory conditions in a model system and
determine the effect of whole blood on the rate and extent of biofilm
formation by selected clinically relevant gram-negative bacteria.
Bacterial strains and culture conditions.
The organisms used
in this study, obtained from the stock culture collection of the
Centers for Disease Control and Prevention, Dialysis and Medical Device
Section (DMDS), were Enterobacter cloacae (DMDS 951225),
Pseudomonas aeruginosa (DMDS 971406), and Pantoea
agglomerans (DMDS 984322). Each frozen stock culture was initially
inoculated onto Trypticase soy agar and incubated at 30°C for 24 h. Each culture was then transfered via swab to Butterfield Buffer
(Becton Dickinson and Co., Cockeysville, Md), and a suspension equivalent to a McFarland 0.5 (~108 CFU/ml) standard was
prepared. This suspension was diluted 1:100, and 1 ml was used to
inoculate 100 ml of lactated Ringer's solution and 5% dextrose,
pH 5.35 (D5RL) (Baxter Healthcare Corporation, Deerfield, Ill.),
for a final concentration of ~104 CFU/ml and allowed to
grow for 7 days at room temperature. These cultures in D5RL were
transferred every 7 days by taking 1 ml (~106 CFU/ml was
reached during stationary phase) and adding it to a new 100-ml volume
of D5RL for a final concentration of ~104 CFU/ml.
Conditioning the NCs.
Five milliliters of fresh venous blood
was collected into a 12-ml syringe. Three milliliters of blood was
transferred from the syringe, through the same needle, into a 50-ml
polypropylene clinical tube (Falcon; Becton Dickinson Labware)
containing 27 ml of sterile physiological saline. This diluted (1:10)
human blood was used the day it was drawn. Sterile NCs (ICU Medical, Inc.) were locked together in series (seven at a time) and connected to
a 10-ml syringe on one end. Another 10-ml syringe containing diluted
human blood was attached to the opposite end, and the blood was
injected through the NCs into the opposite syringe, completely
filling the NCs. After 1 h at room temperature, the blood was
flushed once with physiological saline, pH 6.56 (Gibco BRL, Life Technologies).
Biofilm reactor model system design.
Figure
1 shows the design of the model system
used for growing biofilms on NC inner lumens. Three independent
recirculating tubing lines, each holding a set of seven NCs, were
connected to each of seven reactors. Reactors contained 200 ml of D5RL
and were inoculated with gram-negative bacteria (~106
CFU/ml) that had been grown as pure cultures for 7 days on D5RL at room
temperature. Two reactors were inoculated with P. aeruginosa (final concentration of 4.8 × 103 CFU/ml), two were
inoculated with P. agglomerans (final concentration of
5.8 × 103 CFU/ml), and two were inoculated with
E. cloacae (final concentration of 2.2 × 103 CFU/ml).
Batch mode studies.
For the purpose of the experiment, these
systems were first operated in batch mode. Each system was closed
without addition or removal of any component, with the exception of the
gas phase (11). Reactors were placed on a stirring plate
(Bamstead/Thermolyne, Dubuque, Iowa) set at 100 rpm, and the cultures
were mixed at room temperature (21 to 25°C). Sterile silicone tubing
(1.65-mm inside diameter; Cole Parmer, Niles, Ill.) from each reactor
was connected to sets of NCs by means of a peristaltic pump (model no.
7553-80; Cole Parmer), and the cultures were recirculated at a flow
rate of 1.0 ml min
1. For each organism tested, one
reactor was used to test the human blood treatment, and a second one
was used to test nonconditioned NCs. After 5 days of batch mode growth,
the flow was stopped and a connector was removed from each line and
processed for biofilm removal and quantification. Care was taken to
ensure that the solution remained inside the connector during sampling.
This sampling event was considered time zero, since it represented
biofilm growth under batch conditions prior to continuous flow conditions.
Continuous flow studies.
Immediately following collection of
the first connector, which had been exposed under batch mode
conditions, all tubing lines were removed from the reactors and
connected to a continuous feed of D5RL (1 ml/min) and a drain. The
medium flowed continuously through the connectors to a waste container
and was not recirculated. Connectors were removed on days 2, 5, 7, 9, and 13 (day 12 for E. cloacae) and processed for
biofilm quantification. These sample results represented biofilm growth
under continuous flow conditions.
Processing of NCs.
The connectors were removed from the lines
and connected to two 5-ml syringes, one of them via a female-female
luer coupling. One of the syringes contained 5 ml of
phosphate-buffered saline (PBS). While still attached to the syringes,
the outer surface of connectors was disinfected by immersion in 0.525%
sodium hypochlorite (1:10 bleach) for 10 min and then immersion in
a 0.12 M Na2S2O3 solution for
1 min to inactivate the sodium hypochlorite, followed by air
drying. The PBS was gently flushed through the connector from
one syringe to the other to ensure that those bacterial cells that were reversibly attached (4, 8) were removed, leaving on the surface the adherent bacterial biofilms. Following this outer
surface disinfection procedure, connectors were removed from the
syringes and the PBS flush was discarded. To remove and quantify inner
lumen biofilms, connectors were cut in half transversely at their
joint by using a flame-sterilized Handy Cut tool (Craftsman; Sears
Roebuck and Co., Chicago, Ill.) and both halves were dropped into a
tube containing 10 ml of fresh PBS. Biofilms were removed from the
surface by three cycles of sonication for 30 s followed by
vortexing for 30 s. The biofilm suspension was
homogenized, and viable bacterial counts were quantified by plating
serial dilutions onto R2A medium. Plates were incubated for 24 h
at 30°C, and the bacteria were counted. The details of these methods
are described elsewhere (6).
Statistical analysis.
CFU recovered from the inner lumens of
the NCs were converted to logarithmic numbers and compared by applying
a Wilcoxon test using Epi Info software (5). Subsets of
the data were analyzed and compared under the assumption that biofilms
growing in the inner lumens of NCs reached steady state after 5 days of
continuous flow of the i.v. fluid. A biofilm is said to be at steady
state when it is growing in an open system and the net accumulation of
biomass approaches zero because the rate of growth in the biofilm approximates the rate of detachment of cells from the biofilm (2).
Biofilm log densities and standard deviations (SD) are presented
in Fig.
2 through
4. SD
varied depending on the organism.
SD ranges for three replicates
were 0.09 to 0.77 (average = 0.26),
0.03 to 1.53 (average = 0.34), and 0.27 to 1.66 (average = 0.79)
for
E. cloacae, P. aeruginosa, and
P. agglomerans, respectively.
The results presented in Fig.
2 through
4 show that the numbers of CFU
on the NC surface for all time points were higher for
the conditioned
surfaces for all three organisms. The initial
colonization count of the
inner lumen of the connectors after
5 days of batch growth (time zero
in Fig.
2 through
4) was approximately
1 log higher for the
nonconditioned surfaces. Wilcoxon two-sample
tests were run to evaluate
the effect of preconditioning the surfaces.
For each organism, time
zero counts for NCs conditioned with human
blood were significantly
higher than counts for nonconditioned
NCs (
P = 0.049).
Further, the extent of biofilm formation over
a 2-week continuous flow
period was higher for conditioned surfaces
than for nonconditioned
surfaces. After day 5 of continuous flow,
all biofilms appeared to have
reached a steady state. However,
over the next 7 or 8 days, the
biofilms growing on nonconditioned
surfaces did not reach the density
levels of the biofilms growing
on conditioned surfaces. The only
exception was day 13 for the
P. aeruginosa biofilms, where
the means were very close, but the
SD was large compared to the SD for
the other
days.
A Wilcoxon test of the data in Fig.
2 from days 7, 9, and 12 (biofilms
at steady state) showed that human blood and nonconditioned
NC biofilm
counts were significantly different for all time points
for
E. cloacae (
P = 0.0001). A Wilcoxon test of the data
in Fig.
3 and
4 showed that at steady state (days 7 through 13),
surfaces
conditioned with human blood were significantly different from
nonconditioned surfaces for all time points for
P. aeruginosa (
P = 0.007) and
P. agglomerans (
P = 0.001).
Ideally, a system designed to model biofilm formation on an indwelling
medical device would be one that simulated, as closely
as possible, the
conditions the device was exposed to in the patient
(in vivo). The
medical device utilized in this study was the NC,
which is used to
provide access to CVCs. For this study, we used
a reactor system that
utilized an i.v. fluid as the growth medium
(D5RL) under continuously
flowing conditions (1 ml/min) at ambient
temperature. The organisms
chosen were all clinically relevant
gram-negative bacteria. The system
was initially operated in batch
mode for 5 days to allow for the
initial colonization of the surfaces
of the NCs. Once the system was
switched to continuous flow (time
zero in Fig.
2 through
4), the level
of biofilm accumulation appeared
to reach steady state after day 5 and
remain stationary for the
following 7 to 8 days. We assumed that our
biofilms were at steady
state during sampling days 7, 9, 12, and
13.
When a biofilm reactor is operated in batch mode or closed-system
conditions, changes in chemical composition will occur until
the
limiting nutrient is depleted, even if the system is well
mixed. A
continuous-flow, or open-system, biofilm reactor is not
in equilibrium,
due to a constant replacement of media and biomass
allowing the system
to approach steady state. It is important
to understand the difference
between batch and open systems when
modeling biofilms in vitro so that
biofilm processes occurring
on indwelling medical devices in vivo can
be reproduced as accurately
as possible. Medical device biofilms will
normally simulate an
open system, with a continuous exchange of
nutrients and biomass.
The use of freshly drawn human blood lends even
greater credibility
to the model by simulating the conditions to which
these devices
would be routinely
exposed.
Our results showed that this system produced reproducible biofilms, as
shown by the relatively small SD of our data, which
according to Tilt
and Hamilton (
17) fall within the expected
and acceptable
range for repeatability precision of a
protocol.
In conclusion, a model system for reproducibly growing and testing
biofilms of clinically relevant gram-negative bacteria
has been
developed. Additional testing using other organisms,
media, and
devices, with the same basic system design, could support
this concept
for routine biofilm studies. Our results also show
that whole blood, in
contrast to specific blood proteins, enhanced
the adhesion and biofilm
formation of selected gram-negative bacteria.
This study suggests that
drawing blood through the same intravascular
access line where fluids
are being administered may enhance the
rapid growth of gram-negative
microorganisms that can colonize
the access port and become a source of
bloodstream infection in
patients.
 |
ACKNOWLEDGMENTS |
We acknowledge the helpful suggestions of Roger Bayston of the
Biomaterials-Related Infection Group, Division of Microbiology and
Infectious Diseases, University of Nottingham, and Matthew Arduino and
Michael Bell of the Division of Healthcare Quality Promotion, Centers
for Disease Control and Prevention, for assistance with statistical
analysis and helpful comments, respectively.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Centers for
Disease Control and Prevention, Mail Stop C-16, 1600 Clifton Rd. NE,
Atlanta, GA 30333. Phone: (404) 639-2321. Fax: (404) 639-3822. E-mail: rmurga{at}cdc.gov.
 |
REFERENCES |
| 1.
|
Abraham, S. N.,
E. H. Beachey, and W. A. Simpson.
1983.
Adherence of Streptococcus pyogenes, Escherichia coli, and Pseudomonas aeruginosa to fibronectin-coated and uncoated epithelial cells.
Infect. Immun.
41:1261-1268[Abstract/Free Full Text].
|
| 2.
|
Characklis, W. G.
1990.
Process analysis, p. 50-51.
In
W. G. Characklis, and K. C. Marshall (ed.), Biofilms. John Wiley & Sons, Inc., New York, N.Y.
|
| 3.
|
Characklis, W. G.,
G. A. McFeters, and K. C. Marshall.
1990.
Physiological ecology in biofilm systems, p. 341-394.
In
W. G. Characklis, and K. C. Marshall (ed.), Biofilms. John Wiley & Sons, Inc., New York, N.Y.
|
| 4.
|
Costerton, J. W.,
K.-J. Cheng,
G. G. Geesey,
T. I. Ladd,
J. C. Nickel,
M. Dasgupta, and T. J. Marrie.
1987.
Bacterial biofilms in nature and disease.
Annu. Rev. Microbiol.
41:435-464[CrossRef][Medline].
|
| 5.
|
Dean, A. G.,
J. A. Dean,
D. Coulombier,
K. A. Brendel,
D. C. Smith,
A. H. Burton,
R. C. Dicker,
K. Sullivan,
R. F. Fagan, and T. G. Arner.
1994.
Epi Info, version 6: a word processing, database, and statistics program for epidemiology and microcomputers.
Centers for Disease Control and Prevention, Atlanta, Ga.
|
| 6.
|
Donlan, R. M.,
R. Murga,
M. Bell,
C. M. Toscano,
J. H. Carr,
T. J. Novicki,
C. Zuckerman,
L. C. Corey, and J. M. Miller.
2001.
Protocol for detection of biofilms on needleless connectors attached to central venous catheters.
J. Clin. Microbiol.
39:750-753[Abstract/Free Full Text].
|
| 7.
|
Elliott, T. S. J.,
H. A. Moss,
S. E. Tebbs,
I. C. Wilson,
R. S. Bonser,
T. R. Graham,
L. P. Burke, and M. H. Faroqui.
1997.
Novel approach to investigate a source of microbial contamination of central venous catheters.
Eur. J. Clin. Microbiol. Infect. Dis.
16:210-213[CrossRef][Medline].
|
| 8.
|
Escher, A., and W. G. Characklis.
1990.
Modeling the initial events in biofilm accumulation, p. 445-486.
In
W. G. Characklis, and K. C. Marshall (ed.), Biofilms. John Wiley & Sons, Inc., New York, N.Y.
|
| 9.
|
Espersen, F.,
B. J. Wilkinson,
B. Gahm-Hansen,
V. Thamdrup Rosdahl, and I. Clemmensen.
1990.
Attachment of staphylococci to silicone catheters in vitro.
APMIS
98:471-478[Medline].
|
| 10.
|
Fridkin, S. K.,
S. Welbel, and R. A. Weinstein.
1997.
Magnitude and prevention of nosocomial infections in the intensive care unit.
Infect. Disease Clin. N. Am.
11:479-496.
|
| 11.
|
Gerhardt, P., and S. W. Drew.
1994.
Liquid culture, p. 224-247.
In
P. Gerhardt, R. G. E. Murray, W. A. Wood, and N. R. Krieg (ed.), Methods for general and molecular bacteriology. American Society for Microbiology, Washington, D.C.
|
| 12.
|
Herrmann, M.,
P. E. Vaudaux,
D. Pittet,
R. Auckendthaler,
P. D. Lew,
F. Schumacher-Pedreau,
G. Peters, and F. A. Waldvogel.
1988.
Fibronectin, fibrinogen, and laminin act as mediators of adherence of clinical staphylococcal isolates to foreign material.
J. Infect. Dis.
158:693-701[Medline].
|
| 13.
|
Imai, S.,
N. Okahashi,
T. Koga,
T. Nisizawa, and S. Hamada.
1984.
Ability of various oral bacteria to bind human plasma fibronectin.
Microbiol. Immunol.
28:863-871[Medline].
|
| 14.
|
Maki, D. G.
1994.
Infections caused by intravascular devices used for infusion therapy: pathogenesis, prevention, and management, p. 155-212.
In
A. L. Bisno, and F. P. Waldvogel (ed.), Infections associated with indwelling medical devices, 2nd ed. ASM Press, Washington, D.C.
|
| 15.
|
Maki, D. G.,
D. A. Goldman, and F. S. Rhame.
1973.
Infection control in intravenous therapy.
Ann. Intern. Med.
79:867-887.
|
| 16.
|
Raad, I. I.,
M. F. Sabbagh,
K. H. Rand, and R. J. Sherertz.
1992.
Quantitative tip culture methods and the diagnosis of central venous catheter-related infections.
Diagn. Microbiol. Infect. Dis.
15:13-20[CrossRef][Medline].
|
| 17.
|
Tilt, N., and M. A. Hamilton.
1999.
Repeatability and reproducibility of germicide tests: a literature review.
J. AOAC Int.
82:384-389[Medline].
|
| 18.
|
Vaudaux, P. E.,
D. P. Lew, and F. A. Waldvogel.
1994.
Host factors predisposing to and influencing therapy of foreign body infections, p. 1-29.
In
A. L. Bisno, and F. A. Waldvogel (ed.), Infections associated with indwelling medical devices, 2nd ed. ASM Press, Washington, D.C.
|
| 19.
|
Vercellotti, G. M.,
D. Lussenhop,
P. K. Peterson,
L. T. Furcht,
J. B. McCarthy,
H. S. Jacob, and C. F. Moldow.
1984.
Bacterial adherence to fibronectin and endothelial cells: a possible mechanism for bacterial tissue tropism.
J. Lab. Clin. Med.
103:34-43[Medline].
|
| 20.
|
Vercellotti, G. M.,
J. B. McCarthy,
P. Lindholm,
P. K. Peterson,
H. S. Jacob, and L. T. Furcht.
1985.
Extracellular matrix proteins (fibronectin, laminin, and type IV collagen) bind and aggregate bacteria.
Am. J. Pathol.
120:13-21[Abstract].
|
| 21.
|
Woods, D. E.,
D. C. Straus,
W. G. Johanson, and J. A. Bass.
1981.
Role of fibronectin in the prevention of adherence of Pseudomonas aeruginosa to buccal cells.
J. Infect. Dis.
143:784-790[Medline].
|
Journal of Clinical Microbiology, June 2001, p. 2294-2297, Vol. 39, No. 6
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.6.2294-2297.2001
This article has been cited by other articles:
-
Leid, J. G., Kerr, M., Selgado, C., Johnson, C., Moreno, G., Smith, A., Shirtliff, M. E., O'Toole, G. A., Cope, E. K.
(2009). Flagellum-Mediated Biofilm Defense Mechanisms of Pseudomonas aeruginosa against Host-Derived Lactoferrin. Infect. Immun.
77: 4559-4566
[Abstract]
[Full Text]
-
Litzler, P.-Y., Benard, L., Barbier-Frebourg, N., Vilain, S., Jouenne, T., Beucher, E., Bunel, C., Lemeland, J.-F., Bessou, J.-P.
(2007). Biofilm formation on pyrolytic carbon heart valves: Influence of surface free energy, roughness, and bacterial species.. J. Thorac. Cardiovasc. Surg.
134: 1025-1032
[Abstract]
[Full Text]
-
Cappelli, G., Tetta, C., Canaud, B.
(2005). Is biofilm a cause of silent chronic inflammation in haemodialysis patients? A fascinating working hypothesis. Nephrol Dial Transplant
20: 266-270
[Full Text]
-
Donlan, R. M., Costerton, J. W.
(2002). Biofilms: Survival Mechanisms of Clinically Relevant Microorganisms. Clin. Microbiol. Rev.
15: 167-193
[Abstract]
[Full Text]